Neuroimmunology Research


Expertise:

  • MOG

    Dr. Reyna  Principal Investigator:
    Tania Reyna, MD

     

     

    https://clinicaltrials.gov/study/NCT05063162

    Type of Study:
    International/Randomized Control

    Summary
    The purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD).

    Link to Sponsor’s Website:
    https://www.cosmogstudy.com/

    Luis Garcia

    Study Coordinator:
    Luis Garcia
    Office: 210-450-8451
    Email: garcial38@uthscsa.edu

  • ENABLE

    Dr. Reyna  Principal Investigator:
    Tania Reyna, MD

     

     

    https://clinicaltrials.gov/study/NCT06433752

     

    Type of Study: Observational

    Summary
    The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

     

    Luis Garcia

    Study Coordinator:
    Luis Garcia
    Office: 210-450-8451
    Email: garcial38@uthscsa.edu

  • REMODEL 2

    Dr. Reyna  Principal Investigator:
    Tania Reyna, MD

     

     

    https://clinicaltrials.gov/study/NCT05156281

    Type of Study:
    Interventional/Randomized Control

    Summary
    This study is conducted to compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

    Link to Sponsor’s Website:
    https://premier-neuro.com/wp-content/uploads/2023/06/NOVART_2.pdf

    Randee Kent

    Study Coordinator:
    Randee Kent
    Office: 210-450-0524
    Email: kentbaron@uthscsa.edu